Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons

Neuroscience Letters

Volumn 368, Issue 2, 2004, Pages 181-185

  Kerokoski, Petri ^a   Suuronen, Tiina ^a   Salminen, Antero ^a,b   Soininen, Hilkka ^a,b   Pirttilä, Tuula ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; AMPA; Calpain; Kainate; Neuronal death; p25

Indexed keywords

[1 [(1 FORMYL 2 PHENYLETHYL)CARBAMOYL] 2 METHYLPROPYL]CARBAMIC ACID BENZYL ESTER; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR ANTAGONIST; CALCIUM; CONCANAVALIN A; CYCLIN DEPENDENT KINASE 5; CYCLOTHIAZIDE; DIZOCILPINE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIFEDIPINE; PROTEIN P35;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; DESENSITIZATION; HIPPOCAMPUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT;

ANIMALS; BENZOTHIADIAZINES; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CONCANAVALIN A; CYSTEINE PROTEINASE INHIBITORS; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; NERVE TISSUE PROTEINS; NEURONS; NIFEDIPINE; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; TIME FACTORS;

EID: 4444244237     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.07.007     Document Type: Article

References (28)

1. R.T. Bartus, N.J. Hayward, P.J. Elliott, S.D. Sawyer, K.L. Baker, R.L. Dean, A. Akiyama, J.A. Straub, S.L. Harbeson, and Z. Li Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial administration Stroke 25 1994 2265 2270
2. J.A. Bibb, G.L. Snyder, A. Nishi, Z. Yan, L. Meijer, A.A. Fienberg, L.H. Tsai, Y.T. Kwon, J.A. Girault, A.J. Czernik, R.L. Huganir, H.C. Hemmings Jr., A.C. Nairn, and P. Greengard Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons Nature 402 1999 669 671
3. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells J. Neurosci. 14 1994 187 197
4. J.R. Brorson, C.J. Marcuccilli, and R.J. Miller Delayed antagonism of calpain reduces excitotoxicity in cultured neurons Stroke 26 1995 1259 1266
5. A.M. Buchan, H. Li, S. Cho, and W.A. Pulsinelli Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats Neurosci. Lett. 132 1991 255 258
6. C. Cheng, D.M. Fass, and I.J. Reynolds Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels Brain Res. 849 1999 97 108
7. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol. Rev. 51 1999 7 61
8. P. Kerokoski, T. Suuronen, A. Salminen, H. Soininen, and T. Pirttilä The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis Biochem. Biophys. Res. Commun. 280 2001 998 1002
9. P. Kerokoski, T. Suuronen, A. Salminen, H. Soininen, and T. Pirttilä Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation Biochem. Biophys. Res. Commun. 298 2002 693 698
10. P. Kerokoski, T. Suuronen, A. Salminen, H. Soininen, and T. Pirttilä Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35 Brain Res. 106 2002 50 56
11. G. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S. Hisanaga Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25 J. Biol. Chem. 275 2000 17166 17172
12. Y.T. Kwon, A. Gupta, Y. Zhou, M. Nikolic, and L.H. Tsai Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase Curr. Biol. 10 2000 363 372
13. M.S. Lee, Y.T. Kwon, M. Li, J. Peng, R.M. Friedlander, and L.H. Tsai Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
14. B.S. Li, M.K. Sun, L. Zhang, S. Takahashi, W. Ma, L. Vinade, A.B. Kulkarni, R.O. Brady, and H.C. Pant Regulation of NMDA receptors by cyclin-dependent kinase-5 Proc. Natl. Acad. Sci. U.S.A. 98 2001 12742 12747
15. R. Nath, M. Davis, A.W. Probert, N.C. Kupina, X. Ren, G.P. Schielke, and K.K. Wang Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells Biochem. Biophys. Res. Commun. 274 2000 16 21
16. M.D. Nguyen, R.C. Lariviere, and J.P. Julien Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions Neuron 30 2001 135 147
17. M. Nikolic, M.M. Chou, W. Lu, B.J. Mayer, and L.H. Tsai The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity Nature 395 1998 194 198
18. M. Nikolic, H. Dudek, Y.T. Kwon, Y.F. Ramos, and L.H. Tsai The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation Genes Dev. 10 1996 816 825
19. T. Ohshima, J.M. Ward, C.G. Huh, G. Longenecker, H.C. Veeranna, R.O. Pant, L.J. Brady, A.B. Martin, and Kulkarni Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death Proc. Natl. Acad. Sci. U.S.A. 93 1996 11173 11178
20. G. Paglini, L. Peris, J. Diez-Guerra, S. Quiroga, and A. Caceres The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic EMBO Rep. 2 2001 1139 1144
21. G.N. Patrick, L. Zukerberg, M. Nikolic, S. de la Monte, P. Dikkes, and L.H. Tsai Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
22. D.E. Pellegrini-Giampietro, R.S. Zukin, M.V. Bennett, S. Cho, and W.A. Pulsinelli Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats Proc. Natl. Acad. Sci. U.S.A. 89 1992 10499 10503
23. R.P. Simon, J.H. Swan, T. Griffiths, and B.S. Meldrum Blockade of N-methyl-d-aspartate receptors may protect against ischemic damage in the brain Science 226 1984 850 852
24. E. Stein, J.A. Cox, P.H. Seeburg, and T.A. Verdoorn Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4- isoxazole propionate receptor subtypes Mol. Pharmacol. 42 1992 864 871
25. H. Sugiyama, I. Ito, and C. Hirono A new type of glutamate receptor linked to inositol phospholipid metabolism Nature 325 1987 531 533
26. S. Taniguchi, Y. Fujita, S. Hayashi, A. Kakita, H. Takahashi, S. Murayama, T.C. Saido, S. Hisanaga, T. Iwatsubo, and M. Hasegawa Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains FEBS Lett. 489 2001 46 50
27. M. Vignes Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons Neuropharmacology 40 2001 737 748
28. J. Wang, S. Liu, Y. Fu, J.H. Wang, and Y. Lu Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors Nat. Neurosci. 6 2003 1039 1047